We are live on
!
Find out more
CA
Cullinan Associates Portfolio holdings
AUM
$1.24B
1-Year Est. Return
28.12%
This Fund
S&P 500
This Quarter
Est. Return
+1.46%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$615M
AUM Growth
-$265M
(-30%)
Cap. Flow
-$210M
Cap. Flow
% of AUM
-34.24%
Top 10 Holdings %
Top 10 Hldgs %
73.3%
Holding
97
New
9
Increased
13
Reduced
57
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTN
Raytheon Company
RTN
|
+$3.8M |
| 2 |
L3Harris
LHX
|
+$2.71M |
| 3 |
McKesson
MCK
|
+$2.6M |
| 4 |
UnitedHealth
UNH
|
+$2.21M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$1.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$43.4M |
| 2 |
United Parcel Service
UPS
|
+$25.2M |
| 3 |
Coca-Cola
KO
|
+$19M |
| 4 |
Walt Disney
DIS
|
+$8.27M |
| 5 |
Procter & Gamble
PG
|
+$7.61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 56.11% |
| 2 | Energy | 10.64% |
| 3 | Healthcare | 10.54% |
| 4 | Industrials | 7.86% |
| 5 | Technology | 3.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Walmart Inc
WMT
$893B
| $250M | 40.64% |
10,059,243
-179,466
| -2% | -$4.61M |
|
2
ExxonMobil
XOM
$615B
| $48.8M | 7.94% |
540,367
-50,994
| -9% | -$5.14M |
|
|
3
Procter & Gamble
PG
$347B
| $39.1M | 6.36% |
508,076
-94,372
| -16% | -$7.61M |
|
|
4
Coca-Cola
KO
$353B
| $37.6M | 6.12% |
937,766
-469,063
| -33% | -$19M |
|
|
5
United Parcel Service
UPS
$96.2B
| $26.2M | 4.27% |
303,304
-251,023
| -45% | -$25.2M |
|
6
Johnson & Johnson
JNJ
$599B
| $18.2M | 2.97% |
212,372
-54,016
| -20% | -$5.46M |
|
7
Microsoft
MSFT
$2.99T
| $12M | 1.96% |
348,102
-7,415
| -2% | -$300K |
|
8
Merck
MRK
$307B
| $6.82M | 1.11% |
153,844
-38,960
| -20% | -$2.13M |
|
9
Abbott
ABT
$177B
| $6.03M | 0.98% |
172,900
-114,586
| -40% | -$4.5M |
|
10
Verizon
VZ
$182B
| $5.87M | 0.96% |
116,703
-61,910
| -35% | -$3M |
|
11
Truist Financial
TFC
$62.3B
| $5.84M | 0.95% |
172,365
-78,568
| -31% | -$3.01M |
|
12
ConocoPhillips
COP
$141B
| $5.58M | 0.91% |
92,219
-36,776
| -29% | -$2.87M |
|
13
Medtronic
MDT
$107B
| $5.51M | 0.9% |
107,122
-10,216
| -9% | -$621K |
|
14
SLB Ltd
SLB
$69.4B
| $4.85M | 0.79% |
67,627
-44,475
| -40% | -$4.58M |
|
15
PepsiCo
PEP
$185B
| $4.78M | 0.78% |
58,385
-37,445
| -39% | -$3.23M |
|
16
Colgate-Palmolive
CL
$73.6B
| $4.73M | 0.77% |
82,524
-55,926
| -40% | -$3.75M |
|
17
US Bancorp
USB
$98.4B
| $4.62M | 0.75% |
127,744
-42,013
| -25% | -$1.75M |
|
18
Caterpillar
CAT
$398B
| $4.56M | 0.74% |
55,297
+3,341
| +6% | +$351K |
|
|
T
19
DELISTED
A T & T CORP (NEW)
T
| $4.53M | 0.74% |
128,107
-60,723
| -32% | -$2.15M |
|
20
Pfizer
PFE
$141B
| $4.43M | 0.72% |
166,644
-147,288
| -47% | -$4.2M |
|
|
STI
21
DELISTED
SunTrust Banks, Inc.
STI
| $4.18M | 0.68% |
132,373
-16,562
| -11% | -$645K |
|
22
Baxter International
BAX
$11.4B
| $4.15M | 0.67% |
110,232
-50,526
| -31% | -$2.02M |
|
23
Texas Instruments
TXN
$259B
| $4.07M | 0.66% |
116,700
-12,950
| -10% | -$604K |
|
24
JPMorgan Chase
JPM
$901B
| $3.85M | 0.63% |
72,841
-53,095
| -42% | -$2.99M |
|
25
RTX Corp
RTX
$262B
| $3.67M | 0.6% |
62,793
-52
| -0.1% | -$3.83K |
|
Similar funds
WTA
QI
MP
GX
HCA
NHAS
CCA
XF
Cullinan Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Cullinan Associates held 97 positions worth $615M, down 30% from $879M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Cullinan Associates withdrew a net $210M in Q2 2014, closing 17 positions and reducing 57 holdings. Its most notable exit was VF Corp, an estimated $7.28M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 56% of assets, up from 45% a quarter earlier, followed by Energy and Healthcare.
Against the trend, Cullinan Associates opened a new position in Raytheon Company worth $2.59M.
- Cullinan Associates's largest Q2 2014 buy was Raytheon Company: 39,151 shares worth $2.59M.
- Cullinan Associates added most to Xilinx Inc in Q2 2014, an estimated $1.66M increase.
- Cullinan Associates's biggest Q2 2014 reduction was Bristol-Myers Squibb, cutting an estimated $43.4M.
- Cullinan Associates fully exited VF Corp in Q2 2014, selling an estimated $7.28M.
- Cullinan Associates's ten largest holdings make up 73% of its $615M portfolio in Q2 2014.
- Cullinan Associates opened 9 new positions and closed 17 in Q2 2014.
- Cullinan Associates's portfolio value fell 30% quarter-over-quarter to $615M.
Based on Cullinan Associates's 13F filing for Q2 2014, filed 15 Aug 2014.